New hope for stroke patients: drug may work even 24 hours after symptoms
NCT ID NCT07201688
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This study tests a drug called rhTNK-tPA (Mingfule) to see if it can help people who have had a major stroke and can be treated between 4.5 and 24 hours after symptoms start. About 890 participants will receive either the drug or a placebo. The goal is to see if the drug improves recovery and reduces long-term disability.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Puyang Oilfield General Hospital
RECRUITINGPuyang, Henan, 457001, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.